International Journal of Radiation Oncology * Biology * Physics
Volume 73, Issue 3 , Pages 878-885 , 1 March 2009

Tissue pO2 of Orthotopic 9L and C6 Gliomas and Tumor-Specific Response to Radiotherapy and Hyperoxygenation

  • Nadeem Khan, Ph.D.

      Affiliations

    • EPR Center for Viable Systems, Dartmouth Medical School, Hanover, NH
    • Norris Cotton Cancer Center, Dartmouth-Hitchcock Medical Center, Lebanon, NH
    • Corresponding Author InformationReprint requests to: Nadeem Khan, Ph.D., EPR Center for Viable Systems, 703 Vail, Dartmouth Medical School, Hanover, NH 03755. Tel: (603) 653-3591; Fax: (603) 650-1717
    • ,
  • Hongbin Li, Ph.D.

      Affiliations

    • EPR Center for Viable Systems, Dartmouth Medical School, Hanover, NH
    • ,
  • Huagang Hou, M.D.

      Affiliations

    • EPR Center for Viable Systems, Dartmouth Medical School, Hanover, NH
    • Norris Cotton Cancer Center, Dartmouth-Hitchcock Medical Center, Lebanon, NH
    • ,
  • Jean P. Lariviere, B.S.

      Affiliations

    • EPR Center for Viable Systems, Dartmouth Medical School, Hanover, NH
    • ,
  • David J. Gladstone, Sc.D.

      Affiliations

    • Department of Medicine, Section of Radiation Oncology, Dartmouth-Hitchcock Medical Center, Lebanon, NH
    • ,
  • Eugene Demidenko, Ph.D.

      Affiliations

    • EPR Center for Viable Systems, Dartmouth Medical School, Hanover, NH
    • Norris Cotton Cancer Center, Dartmouth-Hitchcock Medical Center, Lebanon, NH
    • ,
  • Harold M. Swartz, M.D, Ph.D.

      Affiliations

    • EPR Center for Viable Systems, Dartmouth Medical School, Hanover, NH
    • Norris Cotton Cancer Center, Dartmouth-Hitchcock Medical Center, Lebanon, NH

Received 17 July 2008 ,Revised 7 October 2008 ,Accepted 8 October 2008.

References 

  1. Stieber VW, Mehta MP. Advances in radiation therapy for brain tumors. Neurol Clin. 2007;25:1005–1033
  2. Tatum JL, Kelloff GJ, Gillies RJ, et al. Hypoxia: Importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy. Int J Radiat Biol. 2006;82:699–757
  3. Vaupel P. Hypoxia and aggressive tumor phenotype: Implications for therapy and prognosis. Oncologist. 2008;13(Suppl. 3):21–26
  4. Hall EJ. Radiobiology for the radiologist. 5th ed.. Philadelphia: Lippincott Williams & Wilkins; 2000;p. 588
  5. Jensen RL. Hypoxia in the tumorigenesis of gliomas and as a potential target for therapeutic measures. Neurosurg Focus. 2006;20:E24
  6. Kaanders JH, Bussink J, van der Kogel AJ. ARCON: A novel biology-based approach in radiotherapy. Lancet Oncol. 2002;3:728–737
  7. Lanzen JL, Braun RD, Ong AL, et al. Variability in blood flow and pO2 in tumors in response to carbogen breathing. Int J Radiat Oncol Biol Phys. 1998;42:855–859
  8. Dunn TJ, Braun RD, Rhemus WE, et al. The effects of hyperoxic and hypercarbic gases on tumor blood flow. Br J Cancer. 1999;80:117–126
  9. Khan N, Williams BB, Hou H, et al. Repetitive tissue pO2 measurements by electron paramagnetic resonance oximetry: Current status and future potential for experimental and clinical studies. Antioxid Redox Signal. 2007;9:1169–1182
  10. Williams BB, Hou H, Grinberg OY, et al. High spatial resolution multisite EPR oximetry of transient focal cerebral ischemia in the rat. Antioxid Redox Signal. 2007;9:1691–1698
  11. Barth RF. Rat brain tumor models in experimental neuro-oncology: The 9L, C6, T9, F98, RG2 (D74), RT-2 and CNS-1 gliomas. J Neurooncol. 1998;36:91–102
  12. Dai C, Holland EC. Glioma models. Biochim Biophys Acta. 2001;1551:M19–M27
  13. Swartz HM, Clarkson RB. The measurement of oxygen in vivo using EPR techniques. Phys Med Biol. 1998;43:1957–1975
  14. Liu KJ, Bacic G, Hoopes PJ, et al. Assessment of cerebral pO2 by EPR oximetry in rodents: Effects of anesthesia, ischemia, and breathing gas. Brain Res. 1995;685:91–98
  15. Rolett EL, Azzawi A, Liu KJ, et al. Critical oxygen tension in rat brain: A combined (31)P-NMR and EPR oximetry study. Am J Physiol Regul Integr Comp Physiol. 2000;279:R9–R16
  16. Hou H, Khan N, O'Hara JA, et al. Increased oxygenation of intracranial tumors by efaproxyn (efaproxiral), an allosteric hemoglobin modifier: In vivo EPR oximetry study. Int J Radiat Oncol Biol Phys. 2005;61:1503–1509
  17. Denekamp J, Waites T, Fowler JF. Predicting realistic RBE values for clinically relevant radiotherapy schedules. Int J Radiat Biol. 1997;71:681–694
  18. Fowler JF. Modelling altered fractionation schedules. BJR Suppl. 1992;24:187–192
  19. Hou H, Grinberg OY, Grinberg SA, et al. Cerebral tissue oxygenation in reversible focal ischemia in rats: Multi-site EPR oximetry measurements. Physiol Meas. 2005;26:131–141
  20. O'Hara JA, Hou H, Demidenko E, et al. Simultaneous measurement of rat brain cortex PtO2 using EPR oximetry and a fluorescence fiber-optic sensor during normoxia and hyperoxia. Physiol Meas. 2005;26:203–213
  21. Demidenko E. Mixed models: Theory and applications Vol. 734. New York: John Wiley & Sons; 2004;
  22. Demidenko E. The assessment of tumor response to treatment. Appl Stat. 2006;A55:365–377
  23. Cerniglia GJ, Wilson DF, Pawlowski M, et al. Intravascular oxygen distribution in subcutaneous 9L tumors and radiation sensitivity. J Appl Physiol. 1997;82:1939–1945
  24. Teicher BA, Herman TS, Rose CM. Effect of Fluosol-DA on the response of intracranial 9L tumors to X rays and BCNU. Int J Radiat Oncol Biol Phys. 1988;15:1187–1192
  25. Teicher BA, Holden SA, Ara G, et al. Influence of an anti-angiogenic treatment on 9L gliosarcoma: Oxygenation and response to cytotoxic therapy. Int J Cancer. 1995;61:732–737
  26. Wallen CA, Michaelson SM, Wheeler KT. Evidence for an unconventional radiosensitivity of rat 9L subcutaneous tumors. Radiat Res. 1980;84:529–541
  27. Guerin C, Laterra J, Drewes LR, et al. Vascular expression of glucose transporter in experimental brain neoplasms. Am J Pathol. 1992;140:417–425
  28. Beppu T, Kamada K, Yoshida Y, et al. Change of oxygen pressure in glioblastoma tissue under various conditions. J Neurooncol. 2002;58:47–52
  29. Ross BD, Zhao YJ, Neal ER, et al. Contributions of cell kill and posttreatment tumor growth rates to the repopulation of intracerebral 9L tumors after chemotherapy: An MRI study. Proc Natl Acad Sci USA. 1998;95:7012–7017
  30. Vogelbaum MA, Tong JX, Higashikubo R, et al. Transfection of C6 glioma cells with the bax gene and increased sensitivity to treatment with cytosine arabinoside. Neurosurg Focus. 1997;3:Article 3

 Supported by the National Cancer Institute (Grant CA120919) and National Institutes of Health (Grant PO1EB2180).

 Conflict of interest: none.

PII: S0360-3016(08)03663-8

doi: 10.1016/j.ijrobp.2008.10.025

International Journal of Radiation Oncology * Biology * Physics
Volume 73, Issue 3 , Pages 878-885 , 1 March 2009

Article Tools

* Image Usage & Resolution